Viewing Study NCT01746095


Ignite Creation Date: 2025-12-24 @ 2:09 PM
Ignite Modification Date: 2026-02-25 @ 6:59 PM
Study NCT ID: NCT01746095
Status: COMPLETED
Last Update Posted: 2020-01-13
First Post: 2012-12-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients
Sponsor: Savara Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: SAV005-02
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None OTHER View